Jan 9 (Reuters) – Regeneron Pharmaceuticals Chief
Executive Len Schleifer on Monday ripped into Amgen Inc
for its insistence on blocking sales of a rival Regeneron
cholesterol drug while the appeals…
The post CORRECTED-Regeneron CEO says Amgen not putting patients first in patent dispute appeared first on NASDAQ.